Fluzone High-Dose was 24.2% more effective in preventing influenza in adults aged 65 years or older than regular Fluzone in a large-scale clinical trial, vaccine maker Sanofi Pasteur told the Advisory ...

For many years, people who are 65 or older have had the option to get a flu shot that’s specially formulated for them. But the Centers for Disease Control and Prevention declined to recommend that ...

SWIFTWATER, Pa. — Sanofi Pasteur, the vaccines division of Sanofi, released data from a new study examining the ability of its Fluzone High-Dose vaccine to provoke an immune response in elderly and ...

Because older people have a weaker immune response to influenza vaccine than younger people do and are at increased risk for hospitalization and death from flu, the Food and Drug Administration ...

While the flu vaccine is the best way to prepare for flu season, older adults don't have as robust an immune response to the jab as young people do. To address this problem, Sanofi Pasteur formulated ...

Not all flu shots are created equal. That's the message Sanofi wants to convey as it pushes the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices (ACIP) to ...

Fluzone High-Dose Quadrivalent is a vaccine. This vaccine is recommended to help protect against influenza (flu) and associated pneumonia in persons aged 60 years and older. For more information, see ...

Fluzone is a brand-name vaccine used to help prevent certain types of flu. Fluzone comes in two forms: Fluzone Quadrivalent and Fluzone High-Dose Quadrivalent. Fluzone’s cost with and without ...

When making vaccine decisions with their patients, healthcare providers (HCPs) rely on treatment guidance from the Centers for Disease Control and Prevention (CDC). They trust the agency to review the ...

BRIDGEWATER, N.J., March 14, 2025 /PRNewswire/ -- Sanofi announced today the immediate adoption of influenza strains selected by the US Food and Drug Administration (FDA) to advance the manufacturing ...